The 2016 DEA Scheduling Attempt
August 30 — October 13, 2016
In 30 days, a grassroots movement accomplished what had never been done before: forced the DEA to withdraw an emergency scheduling notice. This is the story of how kratom users, scientists, and politicians united against prohibition.
The August 30 Notice
The DEA announced intent to place kratom's primary alkaloids (mitragynine and 7-OH) in Schedule I—same category as heroin and LSD. The justification:
- 15 deaths "associated" with kratom (all polydrug cases)
- "No accepted medical use"
- "High potential for abuse"
The ban would take effect in 30 days—no public comment period, no Congressional review.
The Response
Within days, a multi-pronged campaign emerged:
- Public comments: 23,000+ submitted to Federal Register (vs. typical 50-100)
- Congressional letters: 51 Representatives and 9 Senators questioned the DEA
- Scientific opposition: 8 leading researchers signed letter citing lack of evidence
- Protests: Rallies at DEA headquarters and field offices
- Media coverage: Washington Post, New York Times, VICE, Rolling Stone
On October 12, 2016, the DEA announced it would withdraw the notice and open a full public comment period. It was the first time in DEA history that emergency scheduling was reversed due to public response.
Why It Worked
The campaign succeeded because it combined:
- Personal stories: Veterans, chronic pain patients, recovering addicts shared how kratom saved their lives
- Scientific credibility: Researchers from Columbia, Johns Hopkins, and University of Florida challenged the evidence base
- Bipartisan pressure: Conservative Republicans and progressive Democrats united against overreach
- Economic argument: Estimated $1B industry with 10,000+ jobs at stake
Legacy
The 2016 fight established the American Kratom Association as a political force and created the template for the Kratom Consumer Protection Act strategy—regulation over prohibition.
It also proved that drug policy reform is possible when affected communities organize with scientific backing.
Sources: Federal Register Vol. 81, No. 168 (August 30, 2016); DEA withdrawal notice (October 13, 2016); Congressional Research Service report; American Kratom Association archives.